Novel pyrrolopyridine compounds of formula (I),
1
and their derivatives open potassium channels and are useful for treating a variety of diseases modulated by potassium channels.
式(I)的新型吡咯吡啶化合物及其衍生物能够打开钾通道,对于治疗受钾通道调节的多种疾病有用。
Specific inhibitors of methionyl-tRNA synthetase
申请人:UNIVERSITY OF WASHINGTON
公开号:US10913736B2
公开(公告)日:2021-02-09
The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.
本公开总体上涉及可用于抑制 MetRS 的组合物,以及通过抑制 MetRS 改善疾病的治疗方法。
SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE
申请人:UNIVERSITY OF WASHINGTON
公开号:US20170275279A1
公开(公告)日:2017-09-28
The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.
[EN] PYRROLOPYRIDINE POTASSIUM CHANNEL OPENERS<br/>[FR] REGULATEURS DU CANAL POTASSIQUE A BASE DE PYRROLOPYRIDINE
申请人:ABBOTT LAB
公开号:WO2004060893A1
公开(公告)日:2004-07-22
Novel pyrrolopyridine compounds of formula (I), and their derivatives open potassium channels and are useful for treating a variety of diseases modulated by potassium channels.
[EN] SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE<br/>[FR] INHIBITEURS SPÉCIFIQUES DE LA MÉTHIONYL-TARN SYNTHÉTASE
申请人:UNIV WASHINGTON
公开号:WO2016029146A1
公开(公告)日:2016-02-25
The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.